1018PProgression of disease within 2 years (POD24) is a clinically significant endpoint to identify follicular lymphoma patients with high risk of death. (23rd October 2018) - Sortais, C; Lok, A; Gastinne, T; Mahé, B; Dubruille, V; Blin, N; Howlett, S; Tabah, A; Arnaud, P; Moreau, A; Moreau, P; Leux, C; et al.